Hosted by:
The Rosalind & Morris Goodman Cancer Research Centre
The Montreal General Hospital Foundation
The Research Institute of the MUHC
McGill Faculty of Medicine
McGill Department of Oncology

Experts will discuss CEA, the first clinically-useful human tumour marker found in 70% of cancer patients. This concept-shifting discovery helped shape the modern era of cancer immunology and tumour markers, and is the standard against which other human tumour markers are measured. This marker remains the most frequently used blood test in oncology worldwide, saving innumerable lives.

OPENING ADDRESS
Morag Park, PhD
Director, Goodman Cancer Research Centre
Professor, Diane and Sal Guerrera Chair in Cancer Genetics
Rosalind and Morris Goodman Cancer Research Centre
Departments of Biochemistry, Medicine and Oncology

From the First Tumour Marker to Global Health: Celebrating Oncology at McGill
Eduardo L. Franco, Dr PH, FRSC, FCAHS
James McGill Professor and Minda de Gunzburg Chair,
Chair, Department of Oncology
Director, Division of Cancer Epidemiology

FACILITATOR:
Nicole Beauchemin, PhD
Professor, Departments of Biochemistry, Medicine and Oncology, Goodman Cancer Research Centre (GCRC), McGill University

FEATURING:

VIDEO PRESENTATION:
The Discovery of Carcinoembryonic Antigen (CEA): The First Blood Test for Cancer

KEYNOTE SPEAKERS:
CEA, a Tumour Marker with Surprising Functions
Clifford Paul Stanners, PhD
Professor Emeritus
Goodman Cancer Research Centre and Department of Biochemistry
McGill University

The DNA of Early Cancers
Tom J. Hudson, OC, MD, FRSC
President and Scientific Director
Ontario Institute for Cancer Research, Toronto

CEA: A Marker To Enhance Neoplastic Progression and Resistance to Chemotherapy
J. Milburn Jessup, MD
Chief
Diagnostics Evaluation Branch
Cancer Diagnosis Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute, U.S.A.

In the beginning:
Phil Gold, CC, OQ, MD, PhD, DSc, (Hon., McM), FRCPC, FRSC, MACP
Executive Director, Clinical Research Centre of the Research Institute, MUHC
The Douglas G. Cameron Professor of Medicine
Professor, of Physiology and Oncology, McGill University

CLOSING REMARKS
Vassilios Papadopoulos, DPharm, PhD
Professor of Medicine, Biochemistry, Pharmacology & Therapeutics
Faculty of Medicine, McGill University
Canada Research Chair in Biochemical Pharmacology
Phil Gold Chair in Medicine

A meet-and-greet with Dr. Phil Gold will follow the symposium.

Symposium will be in English.Question and Answer is bilingual.
Light refreshments will be served.
Hurry to register - Seating is limited

For more details on this symposium, please visit http://www.mcgillgcrc.com or
contact by info@mghfoundation.com or call 514-934-8230.

Admissions: General FREE

Interior parking entrance at 2055, Metcalfe St., Montreal H3A 1X7
at $17.75 before 6:00 pm.